These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34824220)

  • 21. Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice.
    Huang W; Chen Z; Zhang L; Tian D; Wang D; Fan D; Wu K; Xia L
    Gastroenterology; 2015 Oct; 149(4):1053-67.e14. PubMed ID: 26065367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deciphering the role of interferon alpha signaling and microenvironment crosstalk in inflammatory breast cancer.
    Provance OK; Lewis-Wambi J
    Breast Cancer Res; 2019 May; 21(1):59. PubMed ID: 31060575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the CCL2/CCR2 Axis in Cancer Immunotherapy: One Stone, Three Birds?
    Fei L; Ren X; Yu H; Zhan Y
    Front Immunol; 2021; 12():771210. PubMed ID: 34804061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CCR2
    Bartneck M; Schrammen PL; Möckel D; Govaere O; Liepelt A; Krenkel O; Ergen C; McCain MV; Eulberg D; Luedde T; Trautwein C; Kiessling F; Reeves H; Lammers T; Tacke F
    Cell Mol Gastroenterol Hepatol; 2019; 7(2):371-390. PubMed ID: 30704985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EZH2 knockdown suppresses the growth and invasion of human inflammatory breast cancer cells.
    Mu Z; Li H; Fernandez SV; Alpaugh KR; Zhang R; Cristofanilli M
    J Exp Clin Cancer Res; 2013 Sep; 32(1):70. PubMed ID: 24294976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner.
    Ogony J; Choi HJ; Lui A; Cristofanilli M; Lewis-Wambi J
    Breast Cancer Res; 2016 Feb; 18(1):25. PubMed ID: 26897526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation.
    Yao M; Fang W; Smart C; Hu Q; Huang S; Alvarez N; Fields P; Cheng N
    Mol Cancer Res; 2019 Feb; 17(2):604-617. PubMed ID: 30446625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion.
    Villodre ES; Hu X; Larson R; Finetti P; Gomez K; Balema W; Stecklein SR; Santiago-Sanchez G; Krishnamurthy S; Song J; Su X; Ueno NT; Tripathy D; Van Laere S; Bertucci F; Vivas-Mejía P; Woodward WA; Debeb BG
    Mol Oncol; 2021 Oct; 15(10):2752-2765. PubMed ID: 34342930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory breast cancer: An overview about the histo-pathological aspect and diagnosis.
    Sahraoui G; Rahoui N; Driss M; Mrad K
    Int Rev Cell Mol Biol; 2024; 384():47-61. PubMed ID: 38637099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity.
    Rypens C; Marsan M; Van Berckelaer C; Billiet C; Melis K; Lopez SP; van Dam P; Devi GR; Finetti P; Ueno NT; Bertucci F; Dirix P; Neven P; Vermeulen P; Dirix L; Van Laere SJ
    Breast Cancer Res Treat; 2020 Apr; 180(2):385-395. PubMed ID: 32043194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice.
    Chen X; Wang Y; Nelson D; Tian S; Mulvey E; Patel B; Conti I; Jaen J; Rollins BJ
    PLoS One; 2016; 11(11):e0165595. PubMed ID: 27820834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC).
    Joglekar-Javadekar M; Van Laere S; Bourne M; Moalwi M; Finetti P; Vermeulen PB; Birnbaum D; Dirix LY; Ueno N; Carter M; Rains J; Ramachandran A; Bertucci F; van Golen KL
    Neoplasia; 2017 Jul; 19(7):564-573. PubMed ID: 28609680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caveolin-1 mediates inflammatory breast cancer cell invasion via the Akt1 pathway and RhoC GTPase.
    Joglekar M; Elbezanti WO; Weitzman MD; Lehman HL; van Golen KL
    J Cell Biochem; 2015 Jun; 116(6):923-33. PubMed ID: 25559359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammatory breast cancer microenvironment repertoire based on DNA methylation data deconvolution reveals actionable targets to enhance the treatment efficacy.
    Calanca N; Faldoni FLC; Souza CP; Souza JS; de Souza Alves BE; Soares MBP; Wong DVT; Lima-Junior RCP; Marchi FA; Rainho CA; Rogatto SR
    J Transl Med; 2024 Aug; 22(1):735. PubMed ID: 39103878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling.
    Allen SG; Chen YC; Madden JM; Fournier CL; Altemus MA; Hiziroglu AB; Cheng YH; Wu ZF; Bao L; Yates JA; Yoon E; Merajver SD
    Sci Rep; 2016 Dec; 6():39190. PubMed ID: 27991524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen Receptor β-Mediated Inhibition of Actin-Based Cell Migration Suppresses Metastasis of Inflammatory Breast Cancer.
    Thomas C; Karagounis IV; Srivastava RK; Vrettos N; Nikolos F; Francois N; Huang M; Gong S; Long Q; Kumar S; Koumenis C; Krishnamurthy S; Ueno NT; Chakrabarti R; Maity A
    Cancer Res; 2021 May; 81(9):2399-2414. PubMed ID: 33514514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synchrotron Fourier-Transform Infrared Microspectroscopy: Characterization of in vitro polarized tumor-associated macrophages stimulated by the secretome of inflammatory and non-inflammatory breast cancer cells.
    Mohamed HT; Kamel G; El-Husseiny N; El-Sharkawy AA; El-Sherif AA; El-Shinawi M; Mohamed MM
    Biochim Biophys Acta Mol Cell Res; 2023 Jan; 1870(1):119367. PubMed ID: 36202317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen receptor α promotes lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways.
    He M; Yu W; Chang C; Miyamoto H; Liu X; Jiang K; Yeh S
    Mol Oncol; 2020 Aug; 14(8):1779-1799. PubMed ID: 32356397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling and characterization of inflammatory breast cancer emboli grown in vitro.
    Lehman HL; Dashner EJ; Lucey M; Vermeulen P; Dirix L; Van Laere S; van Golen KL
    Int J Cancer; 2013 May; 132(10):2283-94. PubMed ID: 23129218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation.
    Izumi K; Fang LY; Mizokami A; Namiki M; Li L; Lin WJ; Chang C
    EMBO Mol Med; 2013 Sep; 5(9):1383-401. PubMed ID: 23982944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.